219 related articles for article (PubMed ID: 24503592)
1. Biomarkers in rare diseases.
Ferlini A; Scotton C; Novelli G
Public Health Genomics; 2013; 16(6):313-21. PubMed ID: 24503592
[TBL] [Abstract][Full Text] [Related]
2. Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?
Brasil S; Pascoal C; Francisco R; Dos Reis Ferreira V; Videira PA; Valadão AG
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31783696
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine in rare diseases: What is next?
Tesi B; Boileau C; Boycott KM; Canaud G; Caulfield M; Choukair D; Hill S; Spielmann M; Wedell A; Wirta V; Nordgren A; Lindstrand A
J Intern Med; 2023 Oct; 294(4):397-412. PubMed ID: 37211972
[TBL] [Abstract][Full Text] [Related]
4. Personalized Medicine: What's in it for Rare Diseases?
Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
[TBL] [Abstract][Full Text] [Related]
5. Preparing for the Future of Rare Diseases.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():641-648. PubMed ID: 29214596
[TBL] [Abstract][Full Text] [Related]
6. The European union policy in the field of rare diseases.
Montserrat Moliner A; Waligóra J
Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
[TBL] [Abstract][Full Text] [Related]
7. Towards efficiency in rare disease research: what is distinctive and important?
Jia J; Shi T
Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
[TBL] [Abstract][Full Text] [Related]
8. The importance of international collaboration for rare diseases research: a European perspective.
Julkowska D; Austin CP; Cutillo CM; Gancberg D; Hager C; Halftermeyer J; Jonker AH; Lau LPL; Norstedt I; Rath A; Schuster R; Simelyte E; van Weely S
Gene Ther; 2017 Sep; 24(9):562-571. PubMed ID: 28440796
[TBL] [Abstract][Full Text] [Related]
9. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
[TBL] [Abstract][Full Text] [Related]
10. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
11. Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group.
Nestler-Parr S; Korchagina D; Toumi M; Pashos CL; Blanchette C; Molsen E; Morel T; Simoens S; Kaló Z; Gatermann R; Redekop W
Value Health; 2018 May; 21(5):493-500. PubMed ID: 29753344
[TBL] [Abstract][Full Text] [Related]
12. Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine.
Gülbakan B; Özgül RK; Yüzbaşıoğlu A; Kohl M; Deigner HP; Özgüç M
EPMA J; 2016; 7(1):24. PubMed ID: 27980697
[TBL] [Abstract][Full Text] [Related]
13. Editorial of Special Issue "Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy".
Zaza G; Gambaro G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545922
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in rare neuromuscular diseases.
Scotton C; Passarelli C; Neri M; Ferlini A
Exp Cell Res; 2014 Jul; 325(1):44-9. PubMed ID: 24389168
[TBL] [Abstract][Full Text] [Related]
15. A Survey of Autoencoder Algorithms to Pave the Diagnosis of Rare Diseases.
Pratella D; Ait-El-Mkadem Saadi S; Bannwarth S; Paquis-Fluckinger V; Bottini S
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639231
[TBL] [Abstract][Full Text] [Related]
16. Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.
Kölker S; Gleich F; Mütze U; Opladen T
Front Endocrinol (Lausanne); 2022; 13():832063. PubMed ID: 35317224
[TBL] [Abstract][Full Text] [Related]
17. Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments.
Klein C; Gahl WA
EMBO Mol Med; 2018 Jan; 10(1):1-3. PubMed ID: 29180354
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report.
Benjamin K; Vernon MK; Patrick DL; Perfetto E; Nestler-Parr S; Burke L
Value Health; 2017; 20(7):838-855. PubMed ID: 28712612
[TBL] [Abstract][Full Text] [Related]
19. [Rare diseases in pulmonary medicine and its challenges].
Wencker M; Teschler H; Vogelmeier C; Koczulla R
Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
[TBL] [Abstract][Full Text] [Related]
20. Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis.
Villella VR; Tosco A; Esposito S; Ferrari E; Bona G; Kroemer G; Raia V; Maiuri L
Minerva Pediatr; 2019 Aug; 71(4):362-370. PubMed ID: 30761822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
